Health inspection·February 12, 2026

F 0552 Ensure that residents are fully informed and understand their health status, care and treatments. Level of Harm - Minimal harm or potential for actual harm Based on review of facility policies and clinical records, as well as staff interviews, it was determined that the facility failed to inform the resident and/or resident representative in advance of the risks and benefits of psychotropic medication (medications that affect the persons mental state, emotions and behavior) use and the treatment alternatives prior to initiating the administration of the medication for two of 30 residents reviewed (Residents 6, 10). Findings Include: The facility's policy regarding the use of psychotropic medications, dated January 27, 2026, indicated that prior to initiating or increasing a psychotropic medication, the resident, family, and/or resident representative must be informed of the benefits, risks, and alternatives for the medications, including any black box warnings for antipsychotic medications, in advance of such initiation or increase. An admission Minimum Data Set (MDS) assessment (a mandated assessment of a resident's abilities and care needs) for Resident 6, dated January 15,2026, revealed that the resident was cognitively intact, received antianxiety and antidepression medications ( psychotropic medications), and had diagnoses that included dementia. Physician's orders for Resident 6, dated February 5, 2026, included an order for the resident to receive 0.5 milligrams (mg) of Ativan (an antianxiety medication) every 6 hours as needed.There was no documented evidence in Resident 6's clinical record that the resident or resident's representative was informed in advance of the risks and benefits and treatment alternatives prior to starting the Ativan. Interview with the Director of Nursing on February 12, 2026, at 11:53 a.m. confirmed that there was no documented evidence in Resident 6's clinical record that the resident or resident's representative was informed in advance of the risks and benefits and treatment alternatives prior to starting the as needed Ativan.A Quarterly MDS for Resident 10 dated February 1, 2026, revealed that the resident was cognitively impaired, was receiving an antipsychotic, antianxiety and an antidepressant medication, and had diagnoses that included anxiety and depression.Physician's orders for Resident 10 dated May 14, 2025, included an order for the resident to receive 12.5mg Trazodone ( an antianxiety medication) twice a day.Physician's orders for Resident 10 dated May 28, 2025, included an order for the resident to receive 25mg trazodone twice a day.There was no documented evidence in Resident 10's clinical record that the resident or resident's representative was informed in advance of the risks and benefits and treatment alternatives prior to starting the Trazodone or increasing the dose of Trazodone.Interview with the Director of Nursing on February 12, 2026, at 11:53 a.m. confirmed that there was no documented evidence in Resident 10's clinical record that the resident or resident's representative was informed in advance of the risks and benefits and treatment alternatives prior to starting the Trazodone or increasing the dose of Trazodone. 28 Pa. Code 201.14(a) Responsibility of licensee. 28 Pa. Code 201.18(b)(2) Management. 28 Pa. Code 201.29(a): Resident rights. Residents Affected - Few Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 4 Event ID: 395563 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 395563 B. Wing A. Building (X3) DATE SURVEY COMPLETED 02/12/2026 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Morrisons Cove Home 429 South Market Street Martinsburg, PA 16662 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)